These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 38290839)
1. Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease. Patel V; Edison P J Neurol Neurosurg Psychiatry; 2024 May; 95(6):581-589. PubMed ID: 38290839 [TBL] [Abstract][Full Text] [Related]
2. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease. de la Monte SM Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795 [TBL] [Abstract][Full Text] [Related]
3. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice. Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163 [TBL] [Abstract][Full Text] [Related]
4. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Aroor AR; McKarns S; Demarco VG; Jia G; Sowers JR Metabolism; 2013 Nov; 62(11):1543-52. PubMed ID: 23932846 [TBL] [Abstract][Full Text] [Related]
5. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease. Litwiniuk A; Bik W; Kalisz M; Baranowska-Bik A Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070553 [TBL] [Abstract][Full Text] [Related]
6. Influence of genetic and cardiometabolic risk factors in Alzheimer's disease. Pasqualetti G; Thayanandan T; Edison P Ageing Res Rev; 2022 Nov; 81():101723. PubMed ID: 36038112 [TBL] [Abstract][Full Text] [Related]
7. Examining the effects of ovarian hormone loss and diet-induced obesity on Alzheimer's disease markers of amyloid-β production and degradation. Hayward GC; Baranowski BJ; Marko DM; MacPherson REK J Neurophysiol; 2021 Apr; 125(4):1068-1078. PubMed ID: 33534663 [TBL] [Abstract][Full Text] [Related]
8. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease. Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654 [TBL] [Abstract][Full Text] [Related]
9. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model. Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560 [TBL] [Abstract][Full Text] [Related]
10. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285 [TBL] [Abstract][Full Text] [Related]
11. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain. Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO Cells; 2020 Jan; 9(1):. PubMed ID: 31963819 [TBL] [Abstract][Full Text] [Related]
12. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation. Al-Kuraishy HM; Jabir MS; Albuhadily AK; Al-Gareeb AI; Rafeeq MF Ageing Res Rev; 2023 Nov; 91():102084. PubMed ID: 37802319 [TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease. Jash K; Gondaliya P; Kirave P; Kulkarni B; Sunkaria A; Kalia K Drug Dev Res; 2020 Apr; 81(2):144-164. PubMed ID: 31820484 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease. Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165 [TBL] [Abstract][Full Text] [Related]
15. Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease. Nuzzo D; Picone P; Baldassano S; Caruana L; Messina E; Marino Gammazza A; Cappello F; Mulè F; Di Carlo M Curr Alzheimer Res; 2015; 12(8):723-35. PubMed ID: 26159189 [TBL] [Abstract][Full Text] [Related]
16. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies. Shieh JC; Huang PT; Lin YF Mol Neurobiol; 2020 Apr; 57(4):1966-1977. PubMed ID: 31900863 [TBL] [Abstract][Full Text] [Related]
19. Obesity as a Risk Factor for Dementia and Alzheimer's Disease: The Role of Leptin. Flores-Cordero JA; Pérez-Pérez A; Jiménez-Cortegana C; Alba G; Flores-Barragán A; Sánchez-Margalet V Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563589 [TBL] [Abstract][Full Text] [Related]
20. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration. Lazar E; Sherzai A; Adeghate J; Sherzai D Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]